Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain

NCT02899884 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02899884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02899884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
November 14, 2016
Completion date
July 16, 2018
Enrollment
3,765 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

breakthrough cancer pain